Description of use

Stratipath Breast is an AI-based precision diagnostic solution for risk stratification of primary invasive breast cancer, enabling identification of patients with increased risk of disease progression. Stratipath Breast uses state-of-the-art AI to analyse images from H&E-stained tissue sections of surgically resected invasive breast tumours and predict prognostic information based on the tumour’s morphology. Stratipath Breast is based on a rigorous scientific development process and validation using multi-source real-world datasets, comprising histopathology images and associated clinical outcome data.

The analysis results are intended to be used as decision support for diagnostic evaluation of breast cancer together with available pathological data and relevant clinical information.